Tower Research Capital (TRC)’s Conformis, Inc. Common Stock CFMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,352
Closed -$11.7K 6513
2023
Q2
$11.7K Buy
5,352
+79
+1% +$112 ﹤0.01% 3944
2023
Q1
$8K Buy
5,273
+3,305
+168% +$7.11K ﹤0.01% 4706
2022
Q4
$7K Buy
1,968
+497
+34% +$1.54K ﹤0.01% 4672
2022
Q3
$7K Buy
1,471
+400
+37% +$2.78K ﹤0.01% 4979
2022
Q2
$9K Buy
1,071
+1,068
+35,600% +$12.2K ﹤0.01% 4631
2022
Q1
$0 Buy
+3
New +$49 ﹤0.01% 7027
2021
Q4
Sell
-3,551
Closed -$118K 6915
2021
Q3
$118K Buy
3,551
+2,969
+510% +$105K ﹤0.01% 2260
2021
Q2
$17K Buy
582
+283
+95% +$6.68K ﹤0.01% 4061
2021
Q1
$7K Sell
299
-1,826
-86% -$49.3K ﹤0.01% 4570
2020
Q4
$35K Buy
+2,125
New +$36.7K ﹤0.01% 3462
2020
Q3
Sell
-660
Closed -$14K 5234
2020
Q2
$14K Buy
660
+567
+610% +$11.9K ﹤0.01% 3883
2020
Q1
$1K Buy
93
+5
+6% +$122 ﹤0.01% 2895
2019
Q4
$3K Buy
88
+69
+363% +$3.27K ﹤0.01% 2996
2019
Q3
$1K Sell
19
-41
-68% -$2.46K ﹤0.01% 3972
2019
Q2
$7K Buy
+60
New +$4.94K ﹤0.01% 2804
2018
Q3
Sell
-328
Closed -$10K 4405
2018
Q2
$10K Buy
+328
New +$11.3K ﹤0.01% 2804
2018
Q1
Sell
-173
Closed -$11K 4037
2017
Q4
$11K Sell
173
-184
-52% -$14.7K ﹤0.01% 2523
2017
Q3
$32K Buy
+357
New +$35.4K ﹤0.01% 2393
2017
Q2
Sell
-94
Closed -$11.3K 3668
2017
Q1
$12K Buy
94
+3
+3% +$508 ﹤0.01% 1662
2016
Q4
$19K Buy
+91
New +$20.1K ﹤0.01% 2212
2016
Q3
Sell
-36
Closed -$6K 4716
2016
Q2
$6K Buy
+36
New +$8.46K ﹤0.01% 3308
2016
Q1
Sell
-10
Closed -$4K 5185
2015
Q4
$4K Sell
10
-11
-52% -$5.52K ﹤0.01% 3291
2015
Q3
$9K Buy
+21
New +$10.6K ﹤0.01% 2417

Other funds holding CFMS

Tower Research Capital (TRC)'s CFMS Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of Conformis, Inc. Common Stock (CFMS) in Q3 2023, closing a stake of 5,352 shares — an estimated $11.7K sold.

Tower Research Capital (TRC) first reported a position in CFMS in Q3 2015 and held it in 23 quarters. The position peaked at $118K in Q3 2021. 1 fund tracked by Wall St. Rank holds CFMS as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining Conformis, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5,352 Conformis, Inc. Common Stock shares in Q3 2023, an estimated $11.7K.
  • Tower Research Capital (TRC) first reported a position in Conformis, Inc. Common Stock in Q3 2015 and held it in 23 quarters.
  • Tower Research Capital (TRC)'s Conformis, Inc. Common Stock position peaked at $118K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.